Alprazolam NDC 63187-444

NDC codes

FDA NDC Directory

Product NDC (as listed)63187-444Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63187-0444Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
63187-444-30	63187044430	30 TABLET in 1 BOTTLE (63187-444-30)Marketed from Mar 3, 2014
63187-444-60	63187044460	60 TABLET in 1 BOTTLE (63187-444-60)Marketed from Mar 3, 2014
63187-444-90	63187044490	90 TABLET in 1 BOTTLE (63187-444-90)Marketed from Mar 3, 2014

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Alprazolam
Generic name (nonproprietary): alprazolam
Active ingredients: Alprazolam — 2 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Proficient Rx LP
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 074909
Marketing start: Mar 25, 1998
Listing expires: Dec 31, 2026
DEA schedule: CIV
Other FDA classes: Benzodiazepines (Chemical structure)
Identifiers: Product ID 63187-444_525278ca-7947-41ac-92cf-b5a4e90dc56cSPL ID 525278ca-7947-41ac-92cf-b5a4e90dc56cSPL set ID 717ce509-f92e-4ec1-a3c6-aeae54d56f4dRxCUI 197321, 197322, 308048UNII YU55MQ3IZY
Pharmacologic class: Benzodiazepine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N463187044430 followed by a unit qualifier and the quantity

Package 63187-0444-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 1, 2020.

Indications (excerpt from the label)

INDICATIONS AND USAGE Anxiety Disorders Alprazolam tablets are indicated for the management of anxiety disorder (a condition corresponding most closely to the APA Diagnostic and Statistical Manual [DSM-III-R] diagnosis of generalized anxiety disorder) or the short-term relief of symptoms of anxiety. Anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. Generalized anxiety disorder is characterized by unrealistic or excessive anxiety and worry (apprehensive expectation) about two or more life circumstances, for a period of six months or longer, during which the person has been bothered more days than not by these concerns. At lea…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 074909

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 074909
Product	Strength	Form · route	Labeler	Product NDC
Alprazolam	Alprazolam 2 mg/1	TabletOral	Bryant Ranch Prepack	71335-0920
Alprazolam	Alprazolam 2 mg/1	TabletOral	PD-Rx Pharmaceuticals, Inc.	55289-523
Alprazolam	Alprazolam 2 mg/1	TabletOral	Sandoz Inc	0781-1089
Alprazolam	Alprazolam 2 mg/1	TabletOral	A-S Medication Solutions	50090-2819